Keyphrases
Fecal Microbiota Transplantation
100%
Placebo
65%
Irritable Bowel Syndrome
60%
Randomized Double-blind Placebo-controlled Study
50%
Meta-analysis
40%
Systematic Meta-analysis
40%
Ulcerative Colitis
32%
During Pregnancy
30%
Multi-strain Probiotics
30%
Crohn's Disease
24%
Vivomixx®
22%
Obesity
22%
Fecal Calprotectin
22%
Escherichia Coli
21%
Active Ulcerative Colitis
21%
Multi-donor
21%
Clinical Remission
21%
Fecal Samples
20%
Inflammatory Bowel Disease
20%
Chronic Pouchitis
20%
Obese Pregnant Women
20%
Randomized Controlled Trial
18%
Gut Microbiota Composition
18%
Probiotic Supplementation
17%
Gut Microbiota
17%
PPSV23
17%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
15%
Ulcerative Colitis Patient
15%
Calprotectin
15%
Intestinal Inflammation
14%
Pregnancy Outcome
13%
Pregnant Women
12%
Inflammatory Markers
12%
Adverse Pregnancy Outcomes
12%
Infant Gut Microbiota
12%
Gestational Weight Gain
12%
Enema
11%
Pneumococcal Conjugate Vaccine
11%
Moderate to Severe
11%
Randomized Placebo-controlled Trial
11%
Add-on Treatment
11%
Phylogenetic Group B2
11%
Placebo-controlled Trial
11%
Immunosuppressive Drugs
11%
Ciprofloxacin
11%
Placebo Groups
10%
Stool Frequency
10%
Polysaccharide Vaccine
10%
Antibody Persistence
10%
Escherichia Coli Nissle
10%
Pharmacology, Toxicology and Pharmaceutical Science
Feces microflora
81%
Placebo
54%
Probiotic Agent
50%
Irritable Colon
50%
Placebo-Controlled Study
40%
Ulcerative Colitis
31%
Symptom
31%
Intestine Flora
24%
Randomized Controlled Trial
20%
Controlled Clinical Trial
20%
Calgranulin
20%
Remission
16%
Inflammatory Bowel Disease
14%
Recurrent Disease
13%
Infection
12%
Ileitis
11%
Crohn's Disease
11%
Escherichia coli
10%
Premature Labor
10%
Dientamoebiasis
10%
Abdominal Discomfort
10%
Ciprofloxacin
10%
Polysaccharide Vaccine
10%
Enterococcus faecium
10%
Vancomycin-Resistant Enterococcus
10%
Observational Study
10%
Immunosuppressive Agent
10%
Clostridium Difficile Infection
10%
Abdominal Pain
10%
Enema
10%
Pneumococcus Vaccine
10%
Bacteriuria
10%
Trichuris suis
10%
Flatulence
10%
Enzyme-Linked Immunosorbent Assay
10%
Microflora
7%
Colitis
6%
Tumor Necrosis Factor
6%
Immunoglobulin G Antibody
6%
Hemoglobin A1c
5%
Adverse Event
5%
Glucagon-Like Peptide-1
5%
Dysbiosis
5%
Pregnancy Diabetes Mellitus
5%
Low Birth Weight
5%
Paromomycin
5%
Metronidazole
5%
Medicine and Dentistry
Probiotic Agent
60%
Placebo
47%
Placebo-Controlled Study
42%
Fecal Microbiota Transplantation
41%
Gut Microbiota
24%
Pouchitis
21%
Neonatal Infant
21%
Irritable Bowel Syndrome
20%
Controlled Clinical Trial
20%
Ulcerative Colitis
20%
Supplementation
13%
Gut Microbiome
11%
Enema
11%
Randomized Controlled Trial
11%
Systematic Review
10%
Faecal Calprotectin
10%
Clostridium Difficile Infection
10%
Enzyme Linked Immunosorbent Assay
10%
Transplantation
10%
Patient with Inflammatory Bowel Disease
10%
Trichuris suis
10%
Ovum
10%
Escherichia coli
10%
Ciprofloxacin
10%
Gestational Weight Gain
9%
Calgranulin
8%
Disease Activity
7%
Childbirth
6%
Hemoglobin A1c
5%
Child
5%
Glucagon Like Peptide 1
5%
Body Mass Index
5%
Gestational Diabetes
5%
Recurrent Disease
5%
